Image

A Genotype-Phenotype Urothelial Cancer Registry

A Genotype-Phenotype Urothelial Cancer Registry

Non Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study is being done to create a registry to help us learn more about urinary and other cancers. This will let us look at large groups of people who do and do not have this kind of cancer.

The investigators will look at risk factors to learn more about how these impact cancer. The investigators will also look at genetic markers. These are genes that are found in a known place. They are often associated with a particular trait. If the gene changes in some way, it may predict cancer or response to treatment. The investigators will look for markers in your saliva.

This registry will help us develop better methods of:

Preventing these cancers. Diagnosing these cancers. Treating these cancers.

Eligibility

Inclusion Criteria:

Urothelial Cancer Cases

  • Must be ≥ 18 years of age AND
  • Must have a diagnosis of urothelial cancer AND
  • Must be an English-speaker

Non-Cancer Control Group

  • Must be ≥ 18 years of age AND
  • Must not have cancer or a personal history of cancer, with the exception of skin cancer. AND
  • Must not be a blood relative of cases AND
  • Must not be a blood relative of another control AND
  • Must be an English-speaker

Family Member Control Group:

        In select kindreds with a high prevalence of bladder cancer and/or very early onset bladder
        cancer, first- and second-degree family members of probands may be contacted by the MSKCC
        study team and invited to complete the questionnaire and submit a saliva sample.
          -  Must be ≥ 18 years of age AND
          -  Must be a blood relative of a case participant AND
          -  Must be an English-speaker
        Exclusion Criteria:
          -  Have any condition, which in the opinion of the primary MSKCC clinician or
             investigators precludes their ability to provide informed consent.

Study details
    Urothelial Cancer
    Renal Pelvis Cancer
    Ureter Cancer
    Bladder Cancer

NCT00902590

Memorial Sloan Kettering Cancer Center

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.